Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals

References

• Aceti, A., Pasquazzi, C., Zechini, B., & De, B. C. (2002). Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: The role of hepatitis B and C virus infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 29, 41–48. doi: 10.1097/00042560-200201010-00005
   PubMed Web of Science ®Google Scholar
• Agbaji, O., Thio, C. L., Meloni, S., Graham, C., Muazu, M., Nimzing, L., … Hawkins, C. (2013). Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62, 204–207. doi: 10.1097/QAI.0b013e31827ce536
   PubMed Web of Science ®Google Scholar
• Alter, M. J. (2006). Epidemiology of viral hepatitis and HIV co-infection. Journal of Hepatology, 44, S6–S9. doi: 10.1016/j.jhep.2005.11.004
   PubMed Web of Science ®Google Scholar
• Amico, K. R., Barta, W., Konkle-Parker, D. J., Fisher, J. D., Cornman, D. H., Shuper, P. A., … Fisher, W. A. (2009). The information-motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample. AIDS and Behavior, 13, 66–75. doi: 10.1007/s10461-007-9311-y
   PubMed Web of Science ®Google Scholar
• Amico, K. R., Toro-Alfonso, J., & Fisher, J. D. (2005). An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care, 17, 661–673. doi: 10.1080/09540120500038058
   PubMed Web of Science ®Google Scholar
• Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994). Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). American Journal of Preventive Medicine, 10, 77–84.
   PubMed Web of Science ®Google Scholar
• Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G. (2001). The alcohol use disorders identification test. Guidelines for use in primary care. World Health Organization, Department of Mental Health and Substance Dependence.
   Google Scholar
• Bangsberg, D. R., & Deeks, S. G. (2002). Is average adherence to HIV antiretroviral therapy enough? Journal of General Internal Medicine, 17, 812–813. doi: 10.1046/j.1525-1497.2002.20812.x
   PubMed Web of Science ®Google Scholar
• Bayon, C., Ribera, E., Cabrero, E., Griffa, L., & Burgos, A. (2012). Prevalence of depressive and other central nervous system symptoms in HIV-infected patients treated with HAART in Spain. Journal of the International Association of Physicians in AIDS Care (JIAPAC), 11, 321–328. doi: 10.1177/1545109712448217
   PubMedGoogle Scholar
• Braitstein, P., Justice, A., Bangsberg, D. R., Yip, B., Alfonso, V., Schechter, M. T., … Montaner, J. S. G. (2006). Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS, 20, 323–331. doi: 10.1097/01.aids.0000198091.70325.f4
   PubMed Web of Science ®Google Scholar
• Braitstein, P., Montessori, V., Chan, K., Montaner, J. S., Schechter, M. T., O'Shaughnessy, M. V., & Hogg R. S. (2005). Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: Outcomes from a population-based cohort. AIDS Care, 17, 505–515. doi: 10.1080/09540120412331291733
   PubMed Web of Science ®Google Scholar
• Briongos-Figuero, L. S., Bachiller-Luque, P., Palacios-Martin, T., De Luis-Roman, D., & Eiros-Bouza, J. M. (2011). Depression and health related quality of life among HIV-infected people. European Review for Medical and Pharmacological Sciences, 15, 855–862.
   PubMed Web of Science ®Google Scholar
• Carta, M. G., Angst, J., Moro, M. F., Mura, G., Hardoy, M. C., Balestrieri, C., … Farci, P. (2012). Association of chronic hepatitis C with recurrent brief depression. Journal of Affective Disorders, 141, 361–366. doi: 10.1016/j.jad.2012.03.020
   PubMed Web of Science ®Google Scholar
• Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255–266. doi: 10.1080/09540120050042891
   PubMed Web of Science ®Google Scholar
• Ciccarelli, N., Fabbiani, M., Grima, P., Falasca, K., Tana, M., Baldonero, E., … Di Giambenedetto, S. (2013). Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients. Infection, 41, 1103–1109. doi: 10.1007/s15010-013-0503-2
   PubMed Web of Science ®Google Scholar
• Conen, A., Fehr, J., Glass, T. R., Furrer, H., Weber, R., Vernazza, P., … The Swiss HIV Cohort Study. (2009). Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral Therapy, 14, 349–357.
   PubMed Web of Science ®Google Scholar
• Fisher, J. D., Amico, K. R., Fisher, W. A., & Harman, J. J. (2008). The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Current HIV/AIDS Reports, 5, 193–203. doi: 10.1007/s11904-008-0028-y
   PubMedGoogle Scholar
• Fisher, J. D., Fisher, W. A., Amico, K. R., & Harman, J. J. (2006). An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychology, 25, 462–473. doi: 10.1037/0278-6133.25.4.462
   PubMed Web of Science ®Google Scholar
• Garcia de, O. P., Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 30, 105–110. doi: 10.1097/00042560-200205010-00014
   PubMed Web of Science ®Google Scholar
• Garvey, L. J., Pavese, N., Ramlackhansingh, A., Thomson, E., Allsop, J. M., Politis, M., … Winston, A. (2012). Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation. PLoS ONE, 7, e38980. doi: 10.1371/journal.pone.0038980
   Google Scholar
• Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 58, 181–187.
   PubMed Web of Science ®Google Scholar
• Goulet, J. L., Fultz, S. L., McGinnis, K. A., & Justice, A. C. (2005). Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS, 19(Suppl. 3), S99–S105. doi: 10.1097/01.aids.0000192077.11067.e5
   PubMed Web of Science ®Google Scholar
• Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 52, 180–202. doi: 10.1097/QAI.0b013e3181b18b6e
   PubMed Web of Science ®Google Scholar
• Horvath, K. J., Oakes, J. M., Rosser, B. R., Danilenko, G., Vezina, H., Amico, K. R., … Simoni, J. (2013). Feasibility, acceptability and preliminary efficacy of an online peer-to-peer social support ART adherence intervention. AIDS and Behavior, 17, 2031–2044. doi: 10.1007/s10461-013-0469-1
   PubMed Web of Science ®Google Scholar
• Horvath, K. J., Smolenski, D., & Amico, K. R. (2014). An empirical test of the information-motivation-behavioral skills model of ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings. AIDS Care, 26, 142–151. doi: 10.1080/09540121.2013.802283
   PubMed Web of Science ®Google Scholar
• Jones, M. & Nunez, M. (2011). HIV and hepatitis C co-infection: The role of HAART in HIV/hepatitis C virus management. Current Opinion in HIV and AIDS, 6, 546–552. doi: 10.1097/COH.0b013e32834bcbd9
   PubMed Web of Science ®Google Scholar
• Klein, M. B., Rollet, K. C., Hull, M., Cooper, C., Walmsley, S., Conway, B., & Pick, N. (2013). Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals. Antiviral Therapy, 18, 717–721. doi: 10.3851/IMP2484
   PubMed Web of Science ®Google Scholar
• Klein, M. B., Rollet-Kurhajec, K. C., Moodie, E. E., Yaphe, S., Tyndall, M., Walmsley, S., … Cooper, C. (2014). Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003–2013). AIDS, 28, 1957–1965. doi: 10.1097/QAD.0000000000000377
   PubMed Web of Science ®Google Scholar
• Kohli, A., Shaffer, A., Sherman, A., & Kottilil, S. (2014). Treatment of hepatitis C: A systematic review. Journal of the American Medical Association, 312, 631–640. doi: 10.1001/jama.2014.7085
   PubMed Web of Science ®Google Scholar
• Krusi, A., Wood, E., Montaner, J., & Kerr, T. (2010). Social and structural determinants of HAART access and adherence among injection drug users. International Journal of Drug Policy, 21, 4–9. doi: 10.1016/j.drugpo.2009.08.003
   PubMed Web of Science ®Google Scholar
• LifeWindows Team. (2006). The LifeWindows Information Motivation Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ). Center for Health, Intervention, and Prevention, University of Connecticut. Retrieved from http://www.chip.uconn.edu/chipweb/documents/Research/F_LWIMBARTQuestionnaire.pdf.
   Google Scholar
• Lima, V. D., Harrigan, R., Bangsberg, D. R., Hogg, R. S., Gross, R., Yip, B., & Montaner, J. S. G. (2009). The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50, 529–536. doi: 10.1097/QAI.0b013e31819675e9
   PubMed Web of Science ®Google Scholar
• Lima, V. D., Harrigan, R., Murray, M., Moore, D. M., Wood, E., Hogg, R. S., & Montaner, J. S. G. (2008). Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS, 22, 2371–2380. doi: 10.1097/QAD.0b013e328315cdd3
   PubMed Web of Science ®Google Scholar
• Martel-Laferriere, V., Brinkley, S., Bichoupan, K., Posner, S., Stivala, A., Perumalswami, P., … Branch, A. D. (2014). Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection. HIV Medicine, 15, 108–115. doi: 10.1111/hiv.12086
   PubMed Web of Science ®Google Scholar
• Melvin, D. C., Lee, J. K., Belsey, E., Arnold, J., & Murphy, R. L. (2000). The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy. AIDS, 14, 463–465. doi: 10.1097/00002030-200003100-00023
   PubMed Web of Science ®Google Scholar
• Moodie, E. E., Pant, P. N., & Klein, M. B. (2009). Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts. PLoS ONE, 4, e4517. doi: 10.1371/journal.pone.0004517
   Google Scholar
• Moore, D. J., Blackstone, K., Woods, S. P., Ellis, R. J., Atkinson, J. H., Heaton, R. K., … The HNRC Group and the TMARC Group Igor. (2012). Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care, 24, 1504–1513. doi: 10.1080/09540121.2012.672718
   PubMed Web of Science ®Google Scholar
• Munoz, M., Bayona, J., Sanchez, E., Arevalo, J., Sebastian, J. L., Arteaga, F., … Shin, S. (2011). Matching social support to individual needs: A community-based intervention to improve HIV treatment adherence in a resource-poor setting. AIDS and Behavior, 15, 1454–1464. doi: 10.1007/s10461-010-9697-9
   PubMed Web of Science ®Google Scholar
• Nachega, J. B., Hislop, M., Dowdy, D. W., Lo, M., Omer, S. B., Regensberg, L., … Maartens, G. (2006). Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43, 78–84. doi: 10.1097/01.qai.0000225015.43266.46
   PubMed Web of Science ®Google Scholar
• Nanni, M. G., Caruso, R., Mitchell, A. J., Meggiolaro, E., & Grassi, L. (2015). Depression in HIV infected patients: A review. Current Psychiatry Reports, 17, 530. doi: 10.1007/s11920-014-0530-4
   PubMed Web of Science ®Google Scholar
• Norton, B. L., Park, L., McGrath, L. J., Proeschold Bell, R. J., Muir, A. J., & Naggie, S. (2012). Health care utilization in HIV-infected patients: Assessing the burden of hepatitis C virus coinfection. AIDS Patient Care and STDs, 26, 541–545. doi: 10.1089/apc.2012.0170
   PubMed Web of Science ®Google Scholar
• Ohl, M. E., Perencevich, E., McInnes, D. K., Kim, N., Rimland, D., Akgun, K., … Justice, A. (2013). Antiretroviral adherence among rural compared to urban veterans with HIV infection in the United States. AIDS and Behavior, 17, 174–180. doi: 10.1007/s10461-012-0325-8
   PubMed Web of Science ®Google Scholar
• Ortego, C., Huedo-Medina, T. B., Llorca, J., Sevilla, L., Santos, P., Rodriguez, E., … Vejo, J. (2011). Adherence to highly active antiretroviral therapy (HAART): A meta-analysis. AIDS and Behavior, 15, 1381–1396. doi: 10.1007/s10461-011-9942-x
   PubMed Web of Science ®Google Scholar
• Pantalone, D. W., Hessler, D. M., Bankoff, S. M., & Shah, B. J. (2012). Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men. Journal of Behavioral Medicine, 35, 520–528. doi: 10.1007/s10865-011-9381-1
   PubMed Web of Science ®Google Scholar
• Parsons, J. T., Golub, S. A., Rosof, E., & Holder, C. (2007). Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: A randomized controlled trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46, 443–450. doi: 10.1097/QAI.0b013e318158a461
   PubMed Web of Science ®Google Scholar
• Parsons, J. T., Kowalczyk, W. J., Botsko, M., Tomassilli, J., & Golub, S. A. (2013). Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. AIDS and Behavior, 17, 1478–1487. doi: 10.1007/s10461-013-0463-7
   PubMed Web of Science ®Google Scholar
• Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., … Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30. doi: 10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Pulido, F., Hill, A., van, D. Y., & Moecklinghoff, C. (2012). Impact of hepatitis C co-infection on response to antiretroviral treatment. AIDS Reviews, 14, 124–131.
   PubMed Web of Science ®Google Scholar
• Ripamonti, D., Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., & Suter, F. (2004). Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients. AIDS, 18, 334–337. doi: 10.1097/00002030-200401230-00028
   PubMed Web of Science ®Google Scholar
• Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., … Group the HNRC. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10, 1–14. doi: 10.1017/S1355617704101021
   PubMed Web of Science ®Google Scholar
• Roux, P., Cohen, J., Lascoux-Combe, C., Sogni, P., Winnock, M., Salmon-Ceron, D., … Carrieri, M. P. (2011). Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: The role of the physician. Drug and Alcohol Dependence, 116, 228–232. doi: 10.1016/j.drugalcdep.2010.09.025
   PubMed Web of Science ®Google Scholar
• Roux, P., Lions, C., Cohen, J., Winnock, M., Salmon-Ceron, D., Bani-Sadr, F., … Carrieri, M. P. (2014). Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: Results from the ANRS-CO13-HEPAVIH cohort. Antiviral Therapy, 19, 171–178. doi: 10.3851/IMP2699
   PubMed Web of Science ®Google Scholar
• Shuper, P. A., Neuman, M., Kanteres, F., Baliunas, D., Joharchi, N., & Rehm, J. (2010). Causal considerations on alcohol and HIV/AIDS – a systematic review. Alcohol and Alcoholism, 45, 159–166. doi: 10.1093/alcalc/agp091
   PubMed Web of Science ®Google Scholar
• Simoni, J. M., Huh, D., Wang, Y., Wilson, I. B., Reynolds, N. R., Remien, R. H., … Liu, H. (2014). The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. AIDS and Behavior, 18, 2285–2290. doi: 10.1007/s10461-014-0905-x
   PubMed Web of Science ®Google Scholar
• Sin, N. L., & DiMatteo, M. R. (2014). Depression treatment enhances adherence to antiretroviral therapy: A meta-analysis. Annals of Behavioral Medicine, 47, 259–269. doi: 10.1007/s12160-013-9559-6
   PubMed Web of Science ®Google Scholar
• Starace, F., Massa, A., Amico, K. R., & Fisher, J. D. (2006). Adherence to antiretroviral therapy: An empirical test of the information-motivation-behavioral skills model. Health Psychology, 25, 153–162. doi: 10.1037/0278-6133.25.2.153
   PubMed Web of Science ®Google Scholar
• Suarez-Zarracina, T., Valle-Garay, E., Collazos, J., Montes, A. H., Carcaba, V., Carton, J. A., & Asensi, V. (2012). Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients. Journal of Viral Hepatitis, 19, 685–693. doi: 10.1111/j.1365-2893.2012.01596.x
   PubMed Web of Science ®Google Scholar
• Sulkowski, M., Pol, S., Mallolas, J., Fainboim, H., Cooper, C., Slim, J., … Greaves, W. (2013). Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: A randomised, double-blind, controlled phase 2 trial. The Lancet Infectious Diseases, 13, 597–605. doi: 10.1016/S1473-3099(13)70149-X
   PubMed Web of Science ®Google Scholar
• Sulkowski, M. S. (2013). Current management of hepatitis C virus infection in patients with HIV co-infection. Journal of Infectious Diseases, 207(Suppl. 1), S26–S32. doi: 10.1093/infdis/jis764
   PubMed Web of Science ®Google Scholar
• Sulkowski, M. S., Sherman, K. E., Dieterich, D. T., Bsharat, M., Mahnke, L., Rockstroh, J. K., … Soriano, V. (2013). Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: A randomized trial. Annals of Internal Medicine, 159, 86–96.
   PubMed Web of Science ®Google Scholar
• Sulkowski, M. S., Thomas, D. L., Chaisson, R. E., & Moore, R. D. (2000). Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. Journal of the American Medical Association, 283, 74–80. doi: 10.1001/jama.283.1.74
   PubMed Web of Science ®Google Scholar
• Sun, B., Abadjian, L., Rempel, H., Monto, A., & Pulliam, L. (2013). Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62, 190–196. doi: 10.1097/QAI.0b013e31827b61f1
   PubMed Web of Science ®Google Scholar
• Thorpe, J., Saeed, S., Moodie, E. E., & Klein, M. B. (2011). Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection. AIDS, 25, 967–975. doi: 10.1097/QAD.0b013e3283455e4b
   PubMed Web of Science ®Google Scholar
• Tsui, J. I., Cheng, D. M., Libman, H., Bridden, C., Saitz, R., & Samet, J. H. (2013). Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C. Journal of Studies on Alcohol and Drugs, 74, 266–270. doi: 10.15288/jsad.2013.74.266
   PubMed Web of Science ®Google Scholar
• Uthman, O. A., Magidson, J. F., Safren, S. A., & Nachega, J. B. (2014). Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: A systematic review and meta-analysis. Current HIV/AIDS Reports, 11, 291–307. doi: 10.1007/s11904-014-0220-1
   PubMed Web of Science ®Google Scholar
• Vivithanaporn, P., Nelles, K., DeBlock, L., Newman, S. C., Gill, M. J., & Power, C. (2012). Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS. Journal of the Neurological Sciences, 312, 45–51. doi: 10.1016/j.jns.2011.08.025
   PubMed Web of Science ®Google Scholar
• Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS, 16, 269–277. doi: 10.1097/00002030-200201250-00017
   PubMed Web of Science ®Google Scholar
• Ware, J. E. & Kosinski, M. (2001). Interpreting SF-36 summary health measures: A response. Quality of Life Research, 10, 405–413. doi: 10.1023/A:1012588218728
   PubMed Web of Science ®Google Scholar
• Yoon, J. C., Crane, P. K., Ciechanowski, P. S., Harrington, R. D., Kitahata, M. M., & Crane, H. M. (2011). Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients. AIDS Care, 23, 1208–1218. doi: 10.1080/09540121.2011.555739
   PubMed Web of Science ®Google Scholar